Conmed (CNMD) Other Accumulated Expenses (2010 - 2026)

Conmed (CNMD) has 17 years of Other Accumulated Expenses data on file, last reported at $125.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 2.56% year-over-year to $125.7 million; the trailing twelve-month figure through Mar 2026 stood at $125.7 million (down 2.56% YoY), and the FY2025 full-year result was $138.5 million, up 26.18% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $125.7 million, down from $138.5 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $163.5 million in Q3 2023 and bottomed at $62.5 million in Q1 2022.
• The 5-year median for Other Accumulated Expenses is $125.1 million (2025), against an average of $119.4 million.
• The widest annual swing landed in 2023, when Other Accumulated Expenses surged 104.31%; it then dropped 29.29% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $98.7 million in 2022, then soared by 53.76% to $151.7 million in 2023, then decreased by 27.63% to $109.8 million in 2024, then gained by 26.18% to $138.5 million in 2025, then dropped by 9.27% to $125.7 million in 2026.
• The last three Other Accumulated Expenses figures came in at $125.7 million (Q1 2026), $138.5 million (Q4 2025), and $130.7 million (Q3 2025), per Business Quant data.

Peer Comparison